Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project
Launched by AALBORG UNIVERSITY HOSPITAL · Jan 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The COPDtoParis Project is a clinical trial that is looking at how long-term home-based cycling exercises can help people with Chronic Obstructive Pulmonary Disease (COPD) after they've had a serious worsening of their condition that required a hospital stay. The goal is to see if this type of exercise can help improve how far patients can walk, reduce their COPD symptoms, and enhance their overall quality of life. Participants will use a special pedal-exerciser at home while following along with a fun video cycling experience through an app, making it feel like they are riding outdoors.
To be eligible for this study, participants need to be over 18 years old, have been hospitalized for a COPD flare-up, and live in Aalborg Municipality. They must also be able to provide informed consent and agree to join a rehabilitation program. However, individuals with terminal illnesses, unstable heart conditions, or certain physical limitations that prevent them from cycling will not be eligible. If you join the trial, you'll be part of a group that helps researchers understand the benefits of these home exercises for improving daily activity levels and overall health in COPD patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults at age \> 18 years old
- • Hospital admission with COPD exacerbation with pre-existing COPD diagnosis
- • Citizens of Aalborg Municipality
- • Able to provide informed consent
- • Accepting of referral to rehabilitation
- Exclusion Criteria:
- • Terminal illness
- • Unstable heart disease, i.e., ischemic heart disease, cardiac rhythm disorders
- • Other conditions preventing participating in cycle exercise, e.g., amputation, regimens or earlier or upcoming surgeries preventing seated position, blindness
- • Inability to understand basic Danish oral and written information or giving informed consent.
About Aalborg University Hospital
Aalborg University Hospital is a leading healthcare institution in Denmark, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital actively engages in innovative studies aimed at improving health outcomes across various medical disciplines. With a focus on collaboration and interdisciplinary approaches, Aalborg University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous clinical trials, ensuring adherence to the highest ethical standards and regulatory requirements. The institution is dedicated to fostering a culture of research excellence, contributing valuable insights to the medical community and enhancing treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, , Denmark
Patients applied
Trial Officials
Anna L Stoustrup, MSc
Principal Investigator
a.stoustrup@rn.dk
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported